News

Gladstone in the News November 5, 2020

Coronavirus Testing Finally Gathers Speed

Nature—Melanie Ott, MD, PhD, director of the Gladstone Institute of Virology, explains how the CRISPR-based coronavirus test she recently developed with Nobel Laureate and Senior Investigator Jennifer Doudna, PhD, measures up against conventional, PCR-based tests.

Gladstone Experts COVID-19 Virology Doudna Lab Ott Lab CRISPR/Gene Editing

Gladstone in the News November 1, 2020

California Prop 14 May Change Lives of Sick Kids, Keep Taxpayer Funding of Stem Cell Therapy Research

USA Today—California Proposition 14 put funding for the Stem Cell Research Institute on the ballot this year. Gladstone President Deepak Srivastava, MD, explains how previous funding for stem cell research in California has helped bring the field to a point where stem cell–based therapies are now possible.

Gladstone Experts Cardiovascular Disease Srivastava Lab Stem Cells/iPSCs

Gladstone in the News October 30, 2020

Can We Create Vaccines That Mutate and Spread?

TED—In a March talk selected this week for the TED homepage, Senior Investigator Leor Weinberger, PhD, describes an intriguing type of vaccine his lab is developing and that, like the viruses it aims to neutralize, can mutate and spread from person to person.

Gladstone Experts HIV/AIDS Center for Cell Circuitry Virology Weinberger Lab

Video October 30, 2020

Behind the Scenes of a COVID-19 Lab

Two Gladstone scientist share their recent COVID-19 research

Graduate Students and Postdocs COVID-19 Conklin Lab McDevitt Lab

Video October 28, 2020

Cultural Tax: The Cost of Being the Only or the Few

Tyrone Porter offers his best prescription for confronting what can often be a silent burden and putting a stop to the cultural tax many pay.

Diversity

Gladstone in the News October 28, 2020

Fast, Cheap, Accurate: Researchers Pin Hopes on Nobel Prize–Winning CRISPR Technology to Detect Coronavirus

USA Today—Senior Investigator and Nobel Laureate Jennifer Doudna, PhD, shares her view of CRISPR-based coronavirus detection kits and the possibility they might be deployed during the current pandemic. She and Senior Investigator Melanie Ott, MD, PhD, recently described the test they developed together in a publication posted on the electronic preprint platform bioRxiv.

Gladstone Experts COVID-19 Data Science and Biotechnology Virology Doudna Lab Ott Lab CRISPR/Gene Editing

Gladstone in the News October 28, 2020

Bay Area Health Experts Weigh in on Joe Biden’s Coronavirus Plan

San Francisco Chronicle—Senior Investigator Warner Greene, MD, PhD, endorses presidential candidate Joe Biden’s plan to fight the coronavirus pandemic, calling the plan “rational.”

Gladstone Experts COVID-19 Center for HIV Cure Research Greene Lab

Article October 26, 2020

Halloween Coloring Book

Celebrate Halloween from the comfort of your own home. Gladstone’s Art Department has designed these ghastly coloring sheets for the young or young at heart.

Article October 23, 2020

Philanthropic Leadership Enables Trailblazing Alzheimer’s Research

The Dolby family has supported Gladstone research since 2015

Donor Stories Alzheimer’s Disease

Gladstone in the News October 18, 2020

Fetal Tissue Research, Donald Trump, and the Science behind the Politics

San Francisco Chronicle—Some of the treatments the president received for COVID-19 were developed using cells derived from human embryonic tissue. In addition, many of the COVID-19 vaccine candidates were developed using fetal cell lines. Gladstone Senior Investigator Warner Greene explains how valuable fetal tissue research has been to research on cancer, HIV, spinal cord injuries, and many other diseases. He also describes how the president’s 2019 decision to cut federal funding for fetal cell research has damaged that progress.

Gladstone Experts COVID-19 Virology Greene Lab

Gladstone in the News October 18, 2020

Conservatives Confront Moral Dilemma of Vaccines and Treatments Derived from Fetal Tissue Cells

abc News—In 2019, the Trump administration suspended federal funding for research involving fetal tissue. Gladstone President Deepak Srivastava explains that if the funding ban had been in place over the last few decades, many important drugs—including treatments for COVID-19—would not have been developed.

Gladstone Experts COVID-19 Roddenberry Stem Cell Center Srivastava Lab Stem Cells/iPSCs

Gladstone in the News October 17, 2020

Episode 10: Melanie Ott

Science is Fun!—Director of the Gladstone Institute of Virology Melanie Ott describes her latest work developing a CRISPR-based test for COVID-19, and the prospect for broadly acting antiviral therapeutics.

Gladstone Experts COVID-19 Virology Ott Lab

Article October 15, 2020

Gladstone Investigators Receive 4D Nucleome Award from the NIH

Benoit Bruneau and Katie Pollard study DNA folding to identify the genetic causes of congenital heart disease

Grants News Release Congenital Heart Disease Cardiovascular Disease Data Science and Biotechnology Bruneau Lab Pollard Lab

Article October 14, 2020

Young Scientists Committed to Finding Treatments for Neurodegenerative Diseases

The 2020 Berkelhammer Scholars break new ground in research on dementias, Parkinson’s disease, and neuropsychiatric disorders

Donor Stories Parkinson’s Disease Alzheimer’s Disease Dementia Neurological Disease Akassoglou Lab Kreitzer Lab Mahley Lab Mucke Lab Nakamura Lab

Gladstone in the News October 14, 2020

Trump’s COVID-19 Treatment Developed Using Cells Originally Drawn from Fetal Tissue

abc News—Gladstone President Deepak Srivastava, MD, comments on the fact that the experimental treatments President Trump received for COVID-19 were tested on cells that were derived from fetal tissue decades ago, and expresses concern that the Trump administration’s current ban on the use of fetal tissue for research could slow efforts to curb the pandemic.

Gladstone Experts COVID-19 Cardiovascular Disease Srivastava Lab